Detalhe da pesquisa
1.
Death-associated Protein Kinase-1 Expression and Autophagy in Chronic Lymphocytic Leukemia Are Dependent on Activating Transcription Factor-6 and CCAAT/Enhancer-binding Protein-ß.
J Biol Chem
; 291(42): 22030-22042, 2016 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27590344
2.
Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.
Biochim Biophys Acta
; 1849(3): 317-27, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25615818
3.
Bcrp1 transcription in mouse testis is controlled by a promoter upstream of a novel first exon (E1U) regulated by steroidogenic factor-1.
Biochim Biophys Acta
; 1829(12): 1288-99, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24189494
4.
Induction of multidrug resistance transporter ABCG2 by prolactin in human breast cancer cells.
Mol Pharmacol
; 83(2): 377-88, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23150485
5.
Dasatinib targets chronic myeloid leukemia-CD34+ progenitors as effectively as it targets mature cells.
Haematologica
; 98(6): 896-900, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23065516
6.
Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine.
Biochim Biophys Acta
; 1809(7): 295-305, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21718815
7.
Mining our ABCs: pharmacogenomic approach for evaluating transporter function in cancer drug resistance.
Cancer Cell
; 6(2): 105-7, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15324691
8.
Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.
Chin J Cancer
; 31(2): 73-99, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22098950
9.
Creative solution for implementation of experiential, competency-based palliative care training for internal medicine residents.
J Cancer Educ
; 26(3): 436-43, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21553329
10.
Metformin and Androgen Receptor-Axis-Targeted (ARAT) Agents Induce Two PARP-1-Dependent Cell Death Pathways in Androgen-Sensitive Human Prostate Cancer Cells.
Cancers (Basel)
; 13(4)2021 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33562646
11.
Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2).
Mol Pharmacol
; 78(2): 175-85, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20460431
12.
Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemias.
Clin Cancer Res
; 15(5): 1698-707, 2009 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19223502
13.
Progesterone receptor (PR) isoforms PRA and PRB differentially regulate expression of the breast cancer resistance protein in human placental choriocarcinoma BeWo cells.
Mol Pharmacol
; 73(3): 845-54, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18042733
14.
Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage.
Cancer Res
; 66(10): 5007-11, 2006 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16707421
15.
Flavopiridol synergizes TRAIL cytotoxicity by downregulation of FLIPL.
Cancer Chemother Pharmacol
; 60(3): 313-9, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17187253
16.
Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan.
Cancer Chemother Pharmacol
; 58(3): 374-83, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16404634
17.
Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.
Clin Cancer Res
; 11(23): 8403-12, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16322302
18.
Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene.
Cancer Res
; 64(4): 1247-51, 2004 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14973083
19.
Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin.
Cancer Res
; 63(12): 3228-33, 2003 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12810652
20.
Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport.
Cancer Res
; 63(14): 4048-54, 2003 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12874005